首页> 外国专利> COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR

COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR

机译:包含去甲肾上腺素和减毒剂的药物组合物,用于减缓脑部死亡的潜在潜在器官器官衰竭

摘要

A composition, an infusion solution, a method for treatment, and a kit for intravascular administration for treatment of a brain-dead, heart-beating, respirated, potential organ donor. The composition has noradrenaline and a NET inhibitor for noradrenaline. The NET inhibitor may be cocaine or an analogue thereof or a tricyclic antidepressant. The composition may in addition include adrenaline, hydrocortisone, thyroxin, insulin, triiodotyronine, dopamine, a vasopressor agent, such as desmopressin, and methylprednisolone. The ratio between the NET inhibitor and noradrenaline is about 1:1. The composition may be dissolved in pure water, Ringer's acetate solution or physiological sodium chloride solution. The composition is infused in such an amount as to maintain a mean arterial pressure of about 60 mmHg. The composition may be infused by a pump at a rate of about 1.7 ml/hour decreasing dose-dependent to about 0.4 ml/hour after 24 hours.
机译:组合物,输注溶液,治疗方法和用于血管内给药的试剂盒,用于治疗脑死亡,心跳,呼吸的潜在器官供体。该组合物具有去甲肾上腺素和去甲肾上腺素的NET抑制剂。 NET抑制剂可以是可卡因或其类似物或三环抗抑郁药。该组合物可以另外包括肾上腺素,氢化可的松,甲状腺素,胰岛素,三碘代酪氨酸,多巴胺,升压药,例如去氨加压素和甲基泼尼松龙。 NET抑制剂和去甲肾上腺素之间的比例约为1:1。该组合物可以溶解在纯水,林格氏乙酸盐溶液或生理氯化钠溶液中。以保持约60mmHg的平均动脉压的量注入组合物。可以通过泵以约1.7ml /小时的速率注入组合物,剂量依赖性降低至24小时后的约0.4ml /小时。

著录项

  • 公开/公告号US2016354359A1

    专利类型

  • 公开/公告日2016-12-08

    原文格式PDF

  • 申请/专利权人 VIVOLINE MEDICAL AB;

    申请/专利号US201615241318

  • 发明设计人 STIG STEEN;

    申请日2016-08-19

  • 分类号A61K31/46;A61M5/172;A61K45/06;A61M5/142;A61K31/137;A61K9;

  • 国家 US

  • 入库时间 2022-08-21 13:44:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号